ClinicalTrials.govpublic full text
A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC)
ulcerative colitis, interleukin-23 (il-23) antibody, il-23p19, pediatric, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1009356
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.